You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SCTX Award Disclosure
Lucas Svetlana · SEC Form 4 · Filed Jul 27, 2026
Award
Calculated transaction value
$0
Lucas Svetlana Chief Business Officer
SCTX
Transaction date
Jul 23, 2026
Public filing date
Jul 27, 2026
Filing lag
Filed 4 days later
SCTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 109,426 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001781292-26-000007
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$45K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Scribe Therapeutics, Inc. SCTX Current | Award | Jul 23, 2026 | $0 |
| Scribe Therapeutics, Inc. SCTX | Buy | Jul 23, 2026 | $45K |
| Scribe Therapeutics, Inc. SCTX | Award | Jul 23, 2026 | $0 |
| Scribe Therapeutics, Inc. SCTX | Award | Mar 13, 2026 | $0 |